There is insufficient funding and incentive to conduct large-scale preventive trials on optimal omega-3 supplementation.

“if you took the cost of one phase three anti- ameloid failed drug trial just take one of them right like there's been dozens of them just take the dollars that were spent on one of those guaranteed to fail phase three trials and put that money into a preventive trial that looks at something that's got real feasibility or you know something that's really interesting like the optimal supplementation of DHA in the right PA patient population group we could have an answer and yet you know for obvious reasons there's an incentive to do a phase three drug tile on a candidate with an indd uh there's not an incentive from a financial perspective to study these other things”